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ABSTRACT: Different classes of solvents provide different polarity
values, which influence the solubility of pharmaceutical solids. In this
article, the solubility of mefenamic acid in different classes of organic
solvents, including polar protic, dipolar aprotic, and apolar aprotics
at a range of temperatures from (298 to 323) K are reported. It has
been found that mefenamic acid shows high solubility in dipolar
aprotic solvents (N,N-dimethylacetamide, N,N-dimethylformamide,
ethyl acetate, and propanone), moderate solubility in polar protic
solvents (ethanol and propan-2-ol), and poor solubility in apolar
aprotic solvents (hexane, heptane, and cyclohexane) and water.
■ INTRODUCTION
2-[(2,3-Dimethylphenyl)amino]benzoic acid (C15H15NO2, me-
fenamic acid) is a widely used nonsteroidal anti-inflammatory
and analgesic agent for the treatment of pain caused by
menstrual disorders.1,2 The compound has been known to exist
in two polymorphic forms: Form I and Form II.1−5 An
additional polymorph, Form III, has recently been reported.6
Form I is relatively stable at ambient conditions as compared to
Forms II and III. The order of stability is I > II > III at ambient
conditions. However, above 175 °C, the order of stability
becomes II > I > III due to the enantiotropic relationship of the
polymorphs.6 Form II is expected to be more pharmaceutically
active than Form I because of its higher solubility.7 Although
the solubility value for Form III is yet to be reported, it can be
inferred that Form III is the most pharmaceutically active due
to its lowest value of lattice energy, as compared to Forms I and
II.6 However, due to the metastable characteristic of Forms II
and Form III, the use of Form I in the pharmaceutical
formulations is more practical.3,6
It has been shown that polymorphs of mefenamic acid can be
recrystallized from different solvents.1−6 In order to determine
the best solvent and suitable crystallization methods for
producing different polymorphs of mefenamic acid, it is very
important to have the solubility data of the compound in
various solvents.8 Currently, the availability of such data in the
literature is very limited.5,7,9,10 The solubility data can be obtained
experimentally using a technique known as the isothermal
method.11 The technique basically involves the determination
of a maximum amount of solute that can dissolve in a solvent at a
constant temperature with agitation for a time period between
4 to 24 h. The analysis for the solute can be either done
gravimetrically12 or using spectroscopy.13 Some variations of the
technique are also available, which are described in detailed
elsewhere.11,14 Another experimental technique for the solubility
determination involves heating up a suspension of solid and
solvent to dissolution and detecting the clear point, which is
taken as the solubility point, visually or using optical probes.15 In
the present work, the solubility of mefenamic acid in different
classes of organic solvents, which are dipolar aprotic, polar protic,
and apolar aprotic are measured using the isothermal method
at temperatures ranging from (298 to 323) K. The solvents
are N,N-dimethylacetamide (DMA), N,N-dimethylformamide
(DMF), ethyl acetate (EA) and propanone, ethanol, propan-2-ol
(IPA), hexane, heptane, cyclohexane, and water. The solubility
data of mefenamic acid in ethyl acetate obtained in this work are
compared with the literature.5,7 The enthalpy of dissolution and
Gibbs free energy are computed from the experimental data using
the modified van’t Hoff equation.
■ EXPERIMENTAL SECTION
Materials. Table 1 shows the description of materials used
in this work. Results of powder X-ray diffraction (PXRD)
analysis for mefenamic acid illustrated in Figure 1 show that the
received mefenamic acid is Form I. The characteristics of solvents,
such as dielectric constant (ε), molecule dipole moment (DM),
polarity index (PI), cohesive energy density (E), summation of
hydrogen donor propensity (∑Hd), and summation of hydrogen
acceptor propensity (∑Ha) are shown in Table 2.
Received: August 5, 2013
Accepted: November 6, 2013
Published: November 21, 2013
Article
pubs.acs.org/jced
© 2013 American Chemical Society 3447 dx.doi.org/10.1021/je400714f | J. Chem. Eng. Data 2013, 58, 3447−3452
Solubility Measurement. The isothermal method11 was
used to determine the solubility of mefenamic acid in various
solvents listed in Table 2. An excess of mefenamic acid was
added into glass vials containing two (2) mL of solvent and
shaken in a temperature controlled block (Eppendorf
Thermomixer Shaker) at a range of temperatures between
(298 and 323) K. All samples were maintained at the selected
temperatures for a period of 24 h to reach equilibrium. After
that, the supernatant solutions were separated at isothermal
conditions by filtration using a 0.45 μm PTFE membrane
syringe filter. The supernatant was transferred into an
evaporating dish, which was initially weighed to determine its
empty weight. After the transfer, the evaporating dish was
weighed again to determine the wet weight.
Assay of the supernatants was conducted using the
gravimetric method12 that involves evaporation overnight, i.e.,
approximately a few hours at room temperature initially and
then increased to 60 °C. The evaporating dish was repeatedly
weighed and dried until constant weights were obtained (dry
weight). The information on dry, wet, and empty weights was
used to calculate the solubility of the solute in the solvent and
construct the solubility curve. All of the experimental results
were the average of three replicated experiments. The solubility,
S of solute in the solvents at a particular temperature was
calculated as follows:
= −
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S
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w d (1)
where wo is the empty weight, ww is the wet weight, wd is the
dry weight, and wd − wo is the weight of the solute. In eq 2, m1
is in grams, while ww − wd is the weight of solvent, and m2 is in
grams. An average value was used to calculate the mole fraction
solubility, x1based on the following equation:
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where M1and M2 are the molecular weights of the solute and
the solvent, respectively.16
■ RESULTS AND DISCUSSION
Solubility. The solubilities of mefenamic acid in ethanol,
IPA, water, DMA, DMF, EA, propanone, hexane, heptane, and
cyclohexane in mole fraction measured from (298 to 323) K
with their uncertainties are tabulated in Table 3. On the basis of
the extensive literature review, this is the first time the solubility
data of mefenamic acid in hexane, heptane, and cyclohexane
have been reported. These solubility data are used to construct
linearized van’t Hoff plots as presented in Figure 2. The R2
values of the van’t Hoff plots are between 0.97 and 0.99 and
thus signify the reliability of the experimental solubility data.
The result on the solubility of mefenamic acid in EA obtained
in this work was compared with those in the literature and are
shown in Figure 3. As can be seen, the data show a satisfactory
agreement with that of Park and co-workers.7 The solubility
data in this work deviate less than 10 % with those in the literature
as shown in Table 4. The solubility value of mefenamic acid in
ethanol and ethyl acetate at 298 K were reported by Romero
et al.5 in mole fractions as 0.0018 and 0.0038, respectively. These
values only deviates less than 5 % than those reported in this work,
which was 0.0019 and 0.0039 mol fractions in ethanol and ethyl
acetate, respectively.
The chemical structure of mefenamic acid, which consists of
carboxylic, amine, aromatic, and methyl groups, is shown in
Figure 4. The presence of carboxylic and amine group in its
chemical structure demonstrates polar protic characteristics,
Table 1. Description of Materials Used
chemical
name source
initial mass
fraction
purity
purification
method
analysis
method
mefenamic
acid
Baoji Tianxin
Pharmaceutical
Co. Ltd., China
0.9800 none HPLCa
ethanol Fisher Scientific 0.9990 none GCb
propan-2-ol Fisher Scientific 0.9999 none GCb
N,N-dimethyl
acetamide
Fisher Scientific 0.9900 none GCb
N,N-dimethyl
formamide
Fisher Scientific 0.9900 none GCb
propanone Fisher Scientific 0.9950 none GCb
ethyl acetate Fisher Scientific 0.9950 none GCb
hexane Fisher Scientific 0.9990 none GCb
heptane Fisher Scientific 0.9900 none GCb
cyclohexane Fisher Scientific 0.9900 none GCb
aHigh-performance liquid chromatography. bGas−liquid chromato-
graphy.
Figure 1. Comparison of PXRD patterns of mefenamic acid powder (raw material) in this work with that of major peaks obtained by Kato and
co-workers.3 Solid line, this work; and dashed line, Kato and co-workers.3 RI stands for relative intensities.
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while the aromatic and methyl groups are nonpolar. During the
dissolution process, the carboxylic group of mefenamic acid,
which is more electronegative than the amine group, will
donate a hydrogen atom and form a hydrogen bond with either
polar or dipolar aprotic solvents in the solution. Prior to the
formation of the hydrogen bond between mefenamic acid
molecules and solvents, the solvent−solvent interactions in the
solution need to be broken. As shown in Figure 2, the
solubilities of mefenamic acid are high in dipolar aprotic
solvents studied in the order of DMA, DMF, propanone, EA.
However, the solubilities are moderate in polar protic solvents,
which are IPA and ethanol. The solubilities are low in the
apolar aprotic solvents studied, which are hexane, heptane, and
cyclohexane. Although water is a polar protic solute, mefenamic
acid shows very low solubility in it. In terms of the temperature
Table 2. Characteristics of Polar Protic, Dipolar Aprotic and Apolar Aprotic Solventsa
solvents ε18 DM19 PI18 E20 ∑Hd21,22 ∑Ha21,22
Polar Protic
ethanol 24.55 1.69 5.01 618.87 0.37 0.48
IPA 19.92 1.56 4.57 489.11 0.33 0.56
water 78.3623 1.87 10.2 2095.93 1.17 0.47
Dipolar Aprotic
DMA 37.78 3.70 5.21 439.94 0.78
DMF 36.71 3.82 5.34 463.96 0.74
propanone 20.70 2.88 4.61 362.07 0.04 0.49
EA 6.70 1.78 4.17 300.64 0.45
Apolar Aprotic
hexane 1.88 0.00 0.35 200.76
heptane 1.92 0.00 0.39 200.08
cyclohexane 2.00 0.00 1.02 254.59
aε is the dielectric constant; DM is the molecule dipole moment; PI is the polarity index; E is the cohesive energy density;∑Hd is the summation of
hydrogen donor propensity; and ∑Ha is the summation of hydrogen acceptor propensity.
Table 3. Saturated Mole Fraction Solubility x of Mefenamic
Acid in Different Organic Solvents at Experimental Pressure
(0.1 MPa) and Temperatures T from (298 to 323) Ka
T x T x
K K
solvent solvent
ethanol 298 0.0019 IPA 298 0.0020
303 0.0020 303 0.0024
308 0.0024 308 0.0026
313 0.0032 313 0.0033
318 0.0037 318 0.0040
323 0.0042 323 0.0053
water 298 0.0000 DMA 298 0.1219
303 0.0000 303 0.1377
308 0.0000 308 0.1535
313 0.00001 313 0.1648
318 0.00003 318 0.1753
323 0.00005 323 0.1901
DMF 298 0.0171 EA 298 0.0039
303 0.0208 303 0.0045
308 0.0275 308 0.0055
313 0.0327 313 0.0071
318 0.0391 318 0.0079
323 0.0551 323 0.0096
propanone 298 0.0054 hexane 298 0.0013
303 0.0055 303 0.0014
308 0.0065 308 0.0016
313 0.0070 313 0.0018
318 0.0084 318 0.0020
323 0.0098 323 0.0024
heptane 298 0.0011 cyclohexane 298 0.0009
303 0.0013 303 0.0009
308 0.0015 308 0.0011
313 0.0017 313 0.0012
318 0.0018 318 0.0014
323 0.0022 323 0.0016
aThe standard uncertainty u is u(T) = 1 K; the relative standard
uncertainty, ur(x) = 0.05.
Table 4. Deviation D of Experimental Mefenamic Acid
Solubility S in Ethyl Acetate at Various Temperatures from
Literature Data
T SExperimental SLiterature
7 Da
K 100 w 100 w
298 1.0664 1.00 6.64
303 1.2294 1.18 4.63
308 1.4948 1.45 3.09
313 1.9316 1.80 7.31
318 2.1391 2.20 2.77
323 2.6257 2.70 2.75
aD = |(SExperimental − SLiterature)/SLiterature| × 100.
Table 5. Calculated Dissolution Enthalpy ΔHdiss and Gibbs
Free Energy Change ΔGdiss of Mefenamic Acid in Various
Solvents
ΔHdiss
ΔGdiss at
298 K
ΔGdiss at
308 K
ΔGdiss at
318 K
ΔGdiss at
328 K
kJ·mol−1 kJ·mol−1 kJ·mol−1 kJ·mol−1 kJ·mol−1
solvent
ethanol 27.9025 15.49 15.08 14.66 14.45
IPA 30.3718 15.53 15.03 14.53 14.28
water 119.0427 33.64 30.77 27.91 26.47
DMA 13.8515 5.16 4.87 4.58 4.44
DMF 36.1335 10.17 9.30 8.43 7.99
EA 29.3541 13.80 13.28 12.75 12.49
propanone 18.2663 13.13 12.96 12.78 12.70
hexane 19.3555 16.56 16.47 16.37 16.33
heptane 21.0266 16.87 16.73 16.59 16.52
cyclohexane 20.0705 17.55 17.47 17.38 17.34
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effect, the solubility of mefenamic acid is increased with the
increase of temperature for all of the solvents studied. These
findings are in agreement with Mullin.17
It is widely known that the protic solute is more soluble in
dipolar aprotic solvents followed by polar protic and apolar
aprotic solvents.17 This is probably due to the formation of the
higher strength of the hydrogen bonds between the protic
solute and the dipolar aprotic solvents during the dissolution
process compared to that in polar protic solvents. In apolar aprotic
solvents, no hydrogen bonds are formed. The low solubility values
in apolar aprotic solvents might be due to the weak van der Waals
interaction between the molecules. In water, the protic atoms of
mefenamic acid, which are COO− and N+, have a tendency to
provide hydrogen atoms to water molecules and may form
hydrogen bonds with water. However, the presence of aromatic
and methyl groups in the mefenamic acid chemical structure is
more dominant and influences the structure of the surrounding
water molecules and thus leads to poor solubility.
Figure 2. van’t Hoff plot of the saturated mole fraction solubility of mefenamic acid x and reciprocal temperature in different organic solvents: ◇,
DMA; ■, DMF; Δ, propanone; × , ethyl acetate; *, IPA; ο, ethanol; +, hexane; □, heptane; •, cyclohexane; ◆, water.
Figure 3. Comparison of mass fraction solubility data S of mefenamic acid in ethyl acetate at different temperatures obtained in this work (×) and in
the work by Park and co-workers (◆).7
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Heat of Dissolution and Gibbs Free Energy Change.
Heat of dissolution and Gibbs free energy change during the
dissolution process are important parameters, which are
associated with the solubility behavior of the targeted compound.
The higher energy changes during the dissolution process
indicate high stability in solid phase and lower solubility values.24
Using the linear fitting of the van’t Hoff plot in Figure 2, the
dissolution enthalpy and entropy in respective solvents were
determined. The value of enthalpy of dissolution, ΔHdiss in
J·mol−1, calculated from the graph’s slope in Figure 2, indicated
the amount of heat adsorbed or released during disaggregation
and diffusion of mefenamic acid in each solvent used. The
entropy of dissolution, ΔSdiss in J·(mol·K)−1 obtained from the
y-intercept describes the disorder of the dissolution process. The
relationsip between ΔHdiss and ΔSdiss with the changes of Gibbs
free energy, ΔGdiss, in different solvents is shown by the Gibbs−
Helmholtz equation:25
Δ = Δ − ΔG H T Sdiss diss diss (3)
The calculated values of heat of dissolution, ΔHdiss, and
change in Gibbs free energy are tabulated in Table 5. From this
table, it is clear that the values of ΔHdiss and ΔGdiss are positive in
all solvents studied. These values indicate that the dissolution
process of mefenamic acid in the solvents is endothermic but not
a spontaneous process. The highest values of ΔHdiss and ΔGdiss
were obtained during the dissolution of mefenamic acid in water,
which indicates low solubility or poor solute−solvent inter-
actions. However, the values of ΔHdiss and ΔGdiss were the
lowest ones in DMA, which indicate high solubility or good
solute−solvent interactions.
The plot of Gibbs free energy change (ΔGdiss) studied for
each solvent as a function of temperature is shown in Figure 5.
The decrease of ΔGdiss values with the decrease in the solution
temperature indicates less energy is required to initiate the
dissolution of mefenamic acid in the respective solvents.
Therefore, high solubility or good solute−solvent interactions
are obtained at higher temperature.
Figure 4. Chemical structure of mefenamic acid Form I. Color
representation: gray, carbon; black, hydrogen; blue, nitrogen; and red,
oxygen.
Figure 5. Gibbs free energy change of dissolution ΔGdiss as a function of temperature T in (a) water and (b) organic solvents:◇, DMA; ■, DMF; Δ,
propanone; × , ethyl acetate; blue asterisk, IPA; blue circle, ethanol; red +, hexane; red open square, heptane; and red circle, cyclohexane. Color
representation: black, dipolar aprotic solvents; blue, polar protic solvents; and red, apolar aprotic solvents.
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■ CONCLUSIONS
The solubility of mefenamic acid in three different classes of
organic solvents from (298 to 323) K was determined using
isothermal and gravimetric methods. It was found that the
solubility values increased with temperatures for all of the
solvents tested in this work. Mefenamic acid demonstrates high
solubility values in the dipolar aprotic solvents studied in the
order of DMA, DMF, propanone, and EA, followed by polar
protic solvents, which are IPA and ethanol. The solubilities are
low in the apolar aprotic solvents studied, which are hexane,
heptane, and cyclohexane. Water, which is a polar protic
solvent, however, is not a suitable solvent for the dissolution of
mefenamic acid. Different hydrogen bonding propensities in
the solvents have contributed to different solubility values. The
calculated values of enthalpy and Gibbs free energy change of
dissolution of mefenamic acid in solvents are consistent with
the experimental solubility data.
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(10) Domanńska, U.; Pobudkowska, A.; Pelczarsk, A. Solubility of
Sparingly Soluble Drug Derivatives of Anthranilic Acid. J. Phys. Chem.
B 2011, 115, 2547−2554.
(11) Myerson, A. S. Handbook of Industrial Crystallization; Butter-
worth-Heinemann, Ltd.: Oxford, U.K., 2002.
(12) Abu Bakar, M. R.; Nagy, Z. K.; Saleemi, A. N.; Rielly, C. D. The
Impact of Direct Nucleation Control on Crystal Size Distribution in
Pharmaceutical Crystallization Processes. Cryst. Growth Des. 2009, 9,
1378−1384.
(13) Fujiwara, M.; Chow, P. S.; Ma, D. L.; Braatz, R. D. Paracetamol
Crystallisation Using Laser Backscattering and ATR-FTIR Spectros-
copy: Metastability, Agglomeration and Control. Cryst. Growth Des.
2002, 2, 363−370.
(14) Alvarez, A. J.; Singh, A.; Myerson, A. S. Polymorph Screening:
Comparing a Semi-Automated Approach with a High Throughput
Method. Cryst. Growth Des. 2009, 9, 4181−4188.
(15) Barrett, P.; Glennon, B. Characterizing the Metastable Zone
Width and Solubility Curve Using Lasentec FBRM and PVM. Trans
IChemE Part A 2002, 80, 799−805.
(16) Chen, Z.; Xie, C.; Xu, Z.; Wang, Y.; Zhao, H.; Hao, H.
Determination and Correlation of Solubility Data and Dissolution
Thermodynamic Data of L-Lactide in Different Pure Solvents. J. Chem.
Eng. Data 2013, 58, 143−150.
(17) Mullin, J. W. Crystallization, 4th ed.; Butterworth-Heinemann:
Oxford, U.K., 2001.
(18) Rohani, S.; Horne, S.; Murthy, K. Control of Product Quality in
Batch Crystallization of Pharmaceuticals and Fine Chemicals, Part 1:
Design of the Crystallization Process and the Effect of Solvent. Org.
Process Res. Dev. 2005, 9, 858−872.
(19) Lide, D. R. Handbook of Organic Solvents; CRC Press: Boca
Raton, FL, 1995.
(20) Gu, C.-H.; Li, H.; Gandhi, R. B.; Raghavan, K. Grouping
Solvents by Statistical Analysis of Solvent Property Parameters:
Implication to Polymorph Screening. Int. J. Pharm. 2004, 283, 117−
125.
(21) Abraham, M. H. Hydrogen Bonding. Part 31. Construction of
Scale of Solute Effective or Summation Hydrogen Bond Basicity. J.
Phys. Org. Chem. 1993, 6, 660−684.
(22) Abraham, M. H. Physico-chemical and Biological Processes.
Chem. Soc. Rev. 1993, 73−83.
(23) Miller, J. M.; Rodriguez-Hornedo, N.; Blackburn, A. C.;
Macikenas, D.; Collman, B. M. In Solvent Systems and Their Selection in
Pharmaceutics and Biopharmaceutics; Augustijns, P.; Brewster, M. E.,
Eds.; Springer: New York, 2007; pp 53−109.
(24) Gracin, S.; Rasmuson, A. C. Solubility of Phenylacetic Acid, p-
Hydroxybenzoic Acid, and Ibuprofen in Pure Solvents. J. Chem. Eng.
Data 2002, 47, 1379−1383.
(25) Garcia-Delgado, R. A.; Cotoruelo-Minguez, L. M.; Rodriguez, J.
J. Equilibrium Study of Single-Solute Adsorption of Anionic
Surfactants with Polymeric Xad Resins. Sep. Sci. Technol. 1992, 27,
975−987.
Journal of Chemical & Engineering Data Article
dx.doi.org/10.1021/je400714f | J. Chem. Eng. Data 2013, 58, 3447−34523452
